BARKLEY PMHNP REVIEW QUESTIONS AND CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES
2026 Q&A | LATEST EXAM UPDATE 2026/2027
Core Domains
1. Psychiatric Assessment and Differential Diagnosis
2. Psychopharmacology and Neurobiology
3. Psychotherapy and Therapeutic Modalities
4. Ethical and Legal Principles in Psychiatric Practice
5. Crisis Intervention and Suicide Risk Assessment
6. Child and Adolescent Psychiatric Disorders
7. Substance Use Disorders and Co-occurring Conditions
8. Professional Role, Scope of Practice, and Interprofessional Collaboration
9. Trauma-Informed Care and Cultural Competence
10. Health Promotion, Prevention, and Population Health
Introduction
,This comprehensive examination is designed to assess the knowledge, clinical reasoning, and decision-making
skills essential for psychiatric-mental health nurse practitioner (PMHNP) candidates preparing for board
certification. The assessment covers foundational theory, applied clinical knowledge, regulatory compliance, ethics,
and professional standards across the full spectrum of psychiatric-mental health care. Each question is structured
as a multiple-choice item or clinical scenario that reflects real-world practice and emphasizes critical thinking,
evidence-based intervention, and patient-centered care. Correct answers are verified and accompanied by detailed
rationales to reinforce learning and deepen understanding of key concepts. This examination serves as a rigorous
preparation tool to help candidates identify strengths, address knowledge gaps, and build confidence for success
on the certification examination.
SECTION ONE: QUESTIONS 1–100
Question 1
A 42-year-old patient presents with a two-week history of depressed mood, anhedonia, significant weight loss,
insomnia, fatigue, and feelings of worthlessness. The patient reports that these symptoms began shortly after
losing their job. Which of the following is the most appropriate initial diagnostic consideration?
A. Adjustment Disorder with Depressed Mood
B. Major Depressive Disorder, Single Episode
C. Persistent Depressive Disorder (Dysthymia)
D. Bereavement
,🟢 B. Major Depressive Disorder, Single Episode
🔴 RATIONALE: The patient meets DSM-5-TR criteria for a major depressive episode, including five or more
symptoms (depressed mood, anhedonia, weight loss, insomnia, fatigue, worthlessness) present for at least two
weeks, with clinically significant distress or impairment. While the symptoms are precipitated by job loss, the
severity and number of symptoms exceed what would be expected for an adjustment disorder. Persistent
depressive disorder requires a chronic course of at least two years in adults. Bereavement is not applicable as
the stressor is not a death.
Question 2
Which of the following neurotransmitters is most directly implicated in the pathophysiology of positive
symptoms of schizophrenia, such as hallucinations and delusions?
A. Serotonin
B. Norepinephrine
C. Dopamine
D. Glutamate
🟢 C. Dopamine
🔴 RATIONALE: The dopamine hypothesis of schizophrenia posits that hyperactivity of dopaminergic
neurotransmission, particularly in the mesolimbic pathway, is associated with positive symptoms such as
hallucinations, delusions, and disorganized thinking. Serotonin dysregulation is more closely linked to mood
, disorders and atypical antipsychotic mechanisms. Norepinephrine is involved in arousal and stress responses.
Glutamate hypofunction is implicated in negative and cognitive symptoms.
Question 3
A 28-year-old female patient with generalized anxiety disorder (GAD) has been prescribed sertraline. She calls
the clinic three days after starting the medication, reporting increased anxiety, restlessness, and difficulty
sleeping. What is the most appropriate response?
A. Discontinue sertraline immediately and switch to a different SSRI
B. Reassure the patient that transient activation syndrome is common and often resolves within 1–2 weeks
C. Increase the dose to accelerate therapeutic effect
D. Add a benzodiazepine for long-term management
🟢 B. Reassure the patient that transient activation syndrome is common and often resolves within 1–2 weeks
🔴 RATIONALE: SSRIs such as sertraline can cause transient activation syndrome, characterized by increased
anxiety, agitation, and insomnia in the first days to weeks of treatment. This is typically self-limiting and resolves
as the patient's system adjusts to the medication. Discontinuation is not indicated unless symptoms are severe.
Dose increases would exacerbate the problem. Benzodiazepines may be considered for short-term adjunctive
use but are not first-line for long-term management due to dependence risk.
Question 4
2026 Q&A | LATEST EXAM UPDATE 2026/2027
Core Domains
1. Psychiatric Assessment and Differential Diagnosis
2. Psychopharmacology and Neurobiology
3. Psychotherapy and Therapeutic Modalities
4. Ethical and Legal Principles in Psychiatric Practice
5. Crisis Intervention and Suicide Risk Assessment
6. Child and Adolescent Psychiatric Disorders
7. Substance Use Disorders and Co-occurring Conditions
8. Professional Role, Scope of Practice, and Interprofessional Collaboration
9. Trauma-Informed Care and Cultural Competence
10. Health Promotion, Prevention, and Population Health
Introduction
,This comprehensive examination is designed to assess the knowledge, clinical reasoning, and decision-making
skills essential for psychiatric-mental health nurse practitioner (PMHNP) candidates preparing for board
certification. The assessment covers foundational theory, applied clinical knowledge, regulatory compliance, ethics,
and professional standards across the full spectrum of psychiatric-mental health care. Each question is structured
as a multiple-choice item or clinical scenario that reflects real-world practice and emphasizes critical thinking,
evidence-based intervention, and patient-centered care. Correct answers are verified and accompanied by detailed
rationales to reinforce learning and deepen understanding of key concepts. This examination serves as a rigorous
preparation tool to help candidates identify strengths, address knowledge gaps, and build confidence for success
on the certification examination.
SECTION ONE: QUESTIONS 1–100
Question 1
A 42-year-old patient presents with a two-week history of depressed mood, anhedonia, significant weight loss,
insomnia, fatigue, and feelings of worthlessness. The patient reports that these symptoms began shortly after
losing their job. Which of the following is the most appropriate initial diagnostic consideration?
A. Adjustment Disorder with Depressed Mood
B. Major Depressive Disorder, Single Episode
C. Persistent Depressive Disorder (Dysthymia)
D. Bereavement
,🟢 B. Major Depressive Disorder, Single Episode
🔴 RATIONALE: The patient meets DSM-5-TR criteria for a major depressive episode, including five or more
symptoms (depressed mood, anhedonia, weight loss, insomnia, fatigue, worthlessness) present for at least two
weeks, with clinically significant distress or impairment. While the symptoms are precipitated by job loss, the
severity and number of symptoms exceed what would be expected for an adjustment disorder. Persistent
depressive disorder requires a chronic course of at least two years in adults. Bereavement is not applicable as
the stressor is not a death.
Question 2
Which of the following neurotransmitters is most directly implicated in the pathophysiology of positive
symptoms of schizophrenia, such as hallucinations and delusions?
A. Serotonin
B. Norepinephrine
C. Dopamine
D. Glutamate
🟢 C. Dopamine
🔴 RATIONALE: The dopamine hypothesis of schizophrenia posits that hyperactivity of dopaminergic
neurotransmission, particularly in the mesolimbic pathway, is associated with positive symptoms such as
hallucinations, delusions, and disorganized thinking. Serotonin dysregulation is more closely linked to mood
, disorders and atypical antipsychotic mechanisms. Norepinephrine is involved in arousal and stress responses.
Glutamate hypofunction is implicated in negative and cognitive symptoms.
Question 3
A 28-year-old female patient with generalized anxiety disorder (GAD) has been prescribed sertraline. She calls
the clinic three days after starting the medication, reporting increased anxiety, restlessness, and difficulty
sleeping. What is the most appropriate response?
A. Discontinue sertraline immediately and switch to a different SSRI
B. Reassure the patient that transient activation syndrome is common and often resolves within 1–2 weeks
C. Increase the dose to accelerate therapeutic effect
D. Add a benzodiazepine for long-term management
🟢 B. Reassure the patient that transient activation syndrome is common and often resolves within 1–2 weeks
🔴 RATIONALE: SSRIs such as sertraline can cause transient activation syndrome, characterized by increased
anxiety, agitation, and insomnia in the first days to weeks of treatment. This is typically self-limiting and resolves
as the patient's system adjusts to the medication. Discontinuation is not indicated unless symptoms are severe.
Dose increases would exacerbate the problem. Benzodiazepines may be considered for short-term adjunctive
use but are not first-line for long-term management due to dependence risk.
Question 4
